| Nov 14 |
Hims & Hers drops 22% on Amazon competition concerns (update)
|
| Nov 14 |
Stock Market Today: Chevron Breaks Out, But Biotechs Struggle As Eli Lilly Looks Like Short-Sale Play; Will American Airlines Break Out? (Live Coverage)
|
| Nov 14 |
Hims & Hers cut to underperform by BoA over Amazon competition
|
| Nov 13 |
Hims & Hers launches GLP-1 drug shortage tracker
|
| Nov 13 |
Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
|
| Nov 13 |
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
|
| Nov 12 |
Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality
|
| Nov 11 |
Hims & Hers Health, up 20%, hits all-time high
|
| Nov 9 |
Hims & Hers: Undeservedly Undervalued
|
| Nov 8 |
Hims & Hers: A High-Growth Gem On The Verge Of Big Upside
|
